Trump executive order backs change to Medicare negotiation pushed by drug industry
- President Donald Trump signed a multi-part executive order on April 15, 2025, aiming to lower Medicare prescription drug prices in the United States.
- The order expands efforts initiated during the Biden administration's Medicare Drug Price Negotiation Program by aiming to align Medicare payment rates and explore hospital price matching strategies to help lower prescription drug costs.
- It also includes provisions for lowering insulin prices to as little as 3 cents for low-income or uninsured patients, supports drug importation programs, and requires health centers to pass discounts on insulin and epinephrine to patients.
- The initiatives aim to reduce patient drug expenses by as much as 60%, with projected Medicare savings of $6 billion and a $1.5 billion decrease in out-of-pocket costs for seniors, based on estimates from the White House.
- The administration acknowledged it must collaborate with Congress and warned that tariffs on pharmaceutical imports might raise prices, while critics said payment changes could harm local hospitals relying on high reimbursements.
155 Articles
155 Articles
President Trump Signs EO to Lower Cost of Wide Range of Prescription Medications
President Donald Trump has signed a sweeping executive order to bring down drug prices in America, taking aim at prescription imports, Medicare overcharges, and middlemen in the supply chain. The order could make common medications—including insulin—dramatically cheaper for many Americans. Key Facts: Lowering Cost of Prescriptions Through Executive Action Trump signed the executive order on April 15 to reduce prescription drug costs through var…
Trump's Price Transparency Rule 'Cements' His Legacy of Lowering Healthcare Costs
President Donald Trump's executive order to enforce healthcare price transparency has been hailed as transformative in lowering costs and "cements Trump's legacy" as a leader in healthcare reform.
Trump Signs Order To Help States Import Low-Cost Medications - Nemos News Network
Authored by Lawrence Wilson via The Epoch Times (emphasis ours), President Donald Trump signed an executive order on April 15 that directs a wide range of actions to lower the cost of prescription medications, including through the importation of prescription drugs from Canada by the states. Prescription drugs are displayed at NYC Discount Pharmacy in […]
Drug Pricing Executive Order Boosts Pharmaceutical Industry’s Goals
On Tuesday, President Trump issued an executive order on prescription drug pricing that supports key drug industry efforts to weaken the Inflation Reduction Act’s (IRA) Medicare negotiation program, putting Medicare and beneficiary savings at risk. Since the IRA’s passage, drugmakers have been seeking ways to dilute or sidestep the negotiations, including by bolstering exemptions for certain medications. Since the IRA’s passage, drugmakers have …
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
